Pharmaceutical Executive featured Susan Thomas, chief commercial officer of LucyRx, as part of its Exec on Execs video coverage focused on GLP-1 coverage gaps.
The segment extends LucyRx’s point of view on GLP-1s and reinforces the need for employers to look beyond the immediate cost of therapy. A stronger GLP-1 strategy should consider who needs access, what clinical rules apply, how members are supported and how plans measure value over time.
Share